Approval · Notice of Compliance 8036 · 2006
MICRO + 5 CONCENTRATE: Notice of Compliance 8036
Issued June 16, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8036
- Date
- June 16, 2006
- Company
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Multi-trace element
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MICRO + 5 CONCENTRATE | 02091178 | Cancelled Post Market |
Medicinal ingredients
- ZINC SULFATE 5 MG per ML
- CUPRIC SULFATE 1 MG per ML
- MANGANESE SULFATE 0.5 MG per ML
- CHROMIC CHLORIDE 10 MCG per ML
- SELENIOUS ACID 60 MCG per ML